Yahoo · Oct 28, 2026
National Research: Q3 Earnings Snapshot
(NRC) on Tuesday reported earnings of $4.The Lincoln, Nebraska-based company said it had profit of 21 cents per share.
NR
NYSE · NRC
National Research Corporation
Healthcare · Medical - Healthcare Information Services
$23.83
Up+$0.34 (+1.45%)
Updated Oct 31, 2026, 9:09 PM
SID Score
6.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 397.47M
- P/E ratio
- 24.09
- Dividend yield
- 2.69%
- 52-week range
- $14.61 – $24.40
- Volume
- 86.22K
- Avg. volume
- 96.4K
Price performance · NRC
NRC price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
NRC closed at $23.83 after 21 trading sessions, up 17.10% for the selected period.
- Last close
- $23.83
- Period change
- +17.10%
- Period low
- $20.08
- Period high
- $23.83
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $23.64 | $24.01 | $23.47 | $23.83 | 86.22K |
| Oct 29, 2026 | $23.72 | $24.40 | $23.33 | $23.49 | 124.94K |
| Oct 28, 2026 | $23.24 | $23.83 | $22.10 | $23.47 | 243.12K |
| Oct 27, 2026 | $22.45 | $23.05 | $21.51 | $21.75 | 105.73K |
| Oct 26, 2026 | $21.85 | $22.60 | $21.525 | $22.45 | 93.9K |
| Oct 23, 2026 | $21.13 | $21.99 | $21.04 | $21.93 | 91.3K |
| Oct 22, 2026 | $20.32 | $21.43 | $20.32 | $21.38 | 70.07K |
| Oct 21, 2026 | $20.69 | $20.73 | $20.18 | $20.31 | 48.31K |
| Oct 20, 2026 | $20.47 | $21.07 | $20.425 | $20.69 | 74.69K |
| Oct 19, 2026 | $20.18 | $20.965 | $19.98 | $20.47 | 68.41K |
| Oct 16, 2026 | $21.14 | $21.23 | $19.98 | $20.15 | 70.87K |
| Oct 15, 2026 | $20.61 | $21.50 | $20.61 | $21.11 | 98.47K |
| Oct 14, 2026 | $20.03 | $20.49 | $19.965 | $20.43 | 78.78K |
| Oct 13, 2026 | $20.57 | $20.75 | $20.0788 | $20.17 | 58.93K |
| Oct 12, 2026 | $20.43 | $20.585 | $20.11 | $20.41 | 48.67K |
| Oct 9, 2026 | $20.46 | $20.635 | $20.01 | $20.33 | 52.56K |
| Oct 8, 2026 | $20.185 | $20.52 | $20.11 | $20.42 | 99.24K |
| Oct 7, 2026 | $19.97 | $20.46 | $19.85 | $20.19 | 68.58K |
| Oct 6, 2026 | $20.86 | $20.86 | $20.06 | $20.08 | 80.01K |
| Oct 5, 2026 | $20.44 | $21.15 | $20.22 | $20.78 | 117.69K |
| Oct 2, 2026 | $21.41 | $21.535 | $20.28 | $20.35 | 124.15K |
Latest NRC news
The latest Smart Investors Daily articles mentioning NRC.
Stock researchCompany · Overview
Company
Market Activity
Research & News
NRC research
Overview
Company profile and research snapshot.
Company profile
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 28, 2026 | Citizens | Market Outperform | — |
| Jul 29, 2026 | Citizens | Market Outperform | — |
| Jun 22, 2026 | Citizens | Market Outperform | — |
News briefing
Generated Oct 31, 2026, 5:19 PM
Why Is NRC Up Today?
National Research Corporation shares gained 1.45% today as the company released its Q3 earnings results. The modest upward movement suggests the market is digesting the earnings report with cautious optimism, though sentiment remains neutral overall.
Bottom line: National Research Corporation's 1.45% gain appears tied to a neutral-to-slightly-positive Q3 earnings report that met market expectations without major surprises. Investors should monitor the detailed earnings guidance and management commentary to determine if this move reflects improving fundamentals or simply a lack of negative surprises, as the current information provides limited insight into the company's trajectory.
Benzinga · Oct 28, 2026
Citizens Maintains Market Outperform on NRC Health, Raises Price Target to $27
Citizens analyst Constantine Davides maintains NRC Health (NASDAQ:NRC) with a Market Outperform and raises the price target from $26 to $27.
Yahoo · Oct 28, 2026
National Research Corporation Q3 2026 Earnings Call Summary
Moby summary of National Research Corporation's Q3 2026 earnings call
Yahoo · Oct 27, 2026
NRC Health (NRC) Q3 2026 Earnings Call Transcript
Landmark contract implementation drove 11% revenue growth and margin expansion.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
